🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall goal of this study is to inform the design and establish feasib...
Status
Not Yet Recruiting
Location
Botswana Harvard Health Partnership
Start Date
2026-06-01
Trial ID
NCT07576842
* To evaluate the safety and tolerability of the dual IM pNGVL4a Sig/E7(det...
Status
Terminated
Location
Health Awareness, Inc.
Start Date
2019-05-22
Trial ID
NCT03911076
This study will be looking at what dose of the TA-CIN vaccine is safe and e...
Status
Completed
Location
Women & Infants Center, University of Alabama at Birmingham
Start Date
2019-04-04
Trial ID
NCT02405221
Treatments Being Tested
Phase I clinical trial to assess safety of pNGVL4aCRTE6E7L2 DNA and TA-CIN ...
Status
Recruiting
Location
UAB | The University of Alabama at Birmingham
Start Date
2023-07-10
Trial ID
NCT03913117
Treatments Being Tested
RATIONALE: Vaccines made from DNA or a gene-modified virus may help the bod...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2008-11
Trial ID
NCT00788164
Treatments Being Tested
The primary to assess the safety and tolerability of TA-CIN and anti-PD-1 t...
Status
Withdrawn
Location
Women & Infants Center, University of Alabama at Birmingham
Start Date
2021-08
Trial ID
NCT05132803
Treatments Being Tested
Global elimination of cervical cancer is a feasible goal; however, the coun...
Status
Recruiting
Location
Phrd-Ccr-Kemri
Start Date
2022-05-17
Trial ID
NCT05472311
Treatments Being Tested